Skip navigation

Accelerate@Babraham Start-up Competition: Short-listed Finalists Announced

04 July 2018

Eight life science start-ups will pitch head-to-head on 11th July to win access to the Babraham Research Campus bio-incubator facilities, Accelerate@Babraham

Babraham 03 July, 2018: Launched in January 2018, the objective of Accelerate@Babraham is to support the development of science concepts and the creation of new life science companies by providing access to equipped communal laboratories on short-term agreements, as well as guidance from mentors and introductions to investors. 

The first Accelerate@Babraham Start-up Competition goes one step further, giving up to five new companies the chance to win access to the Accelerate programme for a three-month period from September 2018.  In addition, the winners will receive £20,000, with one of these cash prizes being sponsored by Medimmune.  The competition was launched in May and having received numerous applications, the Accelerate@Babraham team have narrowed down the short-listed finalists to the following eight:

Antiverse Ltd
Kalium Diagnostics
Oppilotech Ltd
Qkine Ltd
Sixfold Bioscience Ltd
SNPr Ltd
VisusNano Ltd

The finalists will pitch to a panel of expert judges, including David Grainger, Partner at Medixci and John Trainer, VP and Head of Partnering and Strategy at MedImmune, at the competition final in The Cambridge Building at the Babraham Research Campus on the 11th July.  The event, starting at 15:45hrs follows on from the final day of the One Nucleus ON Helix conference and is likely to attract a large audience, all keen to support the next generation of start-ups. The event is free to attend and open to all, including ON Helix delegates. However, those wishing to attend must register via the following link:

Having heard presentations from all eight short-listed ventures, the winners will be announced at a drinks reception immediately after the pitches. The successful ventures will secure access to Accelerate@Babraham’s bio-incubator facilities, including communal equipped laboratory space, flexible workspace within the Babraham Research Campus’ stimulating and supportive environment and access to its community hub, which includes office, meeting and social spaces.

In addition, finalists will receive: 
  • £20K non-dilutive funding per venture.
  • 1-2-1 mentoring from world-class scientific, technical and business experts
  • Access to the Babraham Research Campus’ highly experienced life science, healthcare, business and investor networks.
  • Access to Accelerate@Babraham’s top quality programme, bespoke training sessions and final Demo Day – all run by practitioners expert in life science and bio-innovation.

Dr Karolina Zapadka, Business Acceleration Manager, Accelerate@Babraham commented: “We have been delighted with the response to our first Accelerate@Babraham Start-up Competition.  Applications were particularly strong, and it was a difficult process to narrow the field down to our final eight.  All eight finalists put forward strong business cases coupled with a real passion for life sciences spanning diagnostics, computational modelling, accelerated drug development technology and genomics.  I have no doubt that those chosen to move forward to the programme itself will find the process an exciting and motivating learning curve and I’m sure we will also learn quite a bit along the way from them too!”

Further details of the event, including a full agenda, specific timings and a link to register attendance can be found here

To discover more about Accelerate@Babraham please visit

Sarah Brereton, Director, Limewash
Tel: 01223 813 560